Logo.jpg
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
09 mai 2024 08h00 HE | ProPhase Labs, Inc.
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics...
HillmanLogo__Black.png
Hillman Sets First Quarter 2024 Earnings Release and Results Presentation Date
15 avr. 2024 07h30 HE | The Hillman Group
CINCINNATI, April 15, 2024 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and merchandising solutions, plans to host a conference...
priv.jpg
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
09 avr. 2024 09h00 HE | Privia Health Group, Inc.
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
07 mars 2024 08h00 HE | Interpace Biosciences, Inc.
 ●Q4 and FY Revenue of $10.3 million and $40.2 million; a $8.4 million and 26% increase year-over-year ●Q4 and FY Income from Continuing Operations of $0.8 million and $1.1 million; a $7.0 million and...
priv.jpg
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
27 févr. 2024 06h00 HE | Privia Health Group, Inc.
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results; Achieved All 2023 Operating and Financial Guidance Metrics
HillmanLogo__Black.png
Hillman Reports Fourth Quarter 2023 Results; Provides 2024 Guidance
22 févr. 2024 07h30 HE | The Hillman Group
CINCINNATI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, reported...
priv.jpg
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27
23 janv. 2024 08h30 HE | Privia Health Group, Inc.
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27
Picture1.png
Genius Group 2024 Financial Guidance: 110% Growth to $56m - $60m Revenue with Positive EBITDA
22 janv. 2024 08h30 HE | Genius Group Limited
SINGAPORE, Jan. 22, 2024 (GLOBE NEWSWIRE) --  Genius Group Limited Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group,...
LOGO.png
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
11 déc. 2023 08h00 HE | NEXGEL, INC.
LANGHORNE, Pa., Dec. 11, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...
priv.jpg
Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina
03 nov. 2023 06h30 HE | Privia Health Group, Inc.
Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina